Clinical Trials Logo

Clinical Trial Summary

Cutibacterium acnes (C. acnes) is an anaerobic aerotolerant bacteria commonly isolated during revision shoulder surgery. It is increasingly recognized as a pathogen, mainly in implant-related infections. As an anaerobe, it usually needs a prolonged culture incubation time of up to 14 days for growth and the association between implant surgery and C. acnes infection is not always obvious. Unfortunately, prolonged incubation also increases the risk of false positive cultures in isolating organisms that may exist as a result of contamination. Given high rates of positive C. acnes cultures in cases of both primary and revision shoulder surgery, the ramifications of positive C. acnes cultures for clinical decision making remains uncertain. The purpose of this study is to prospectively study the efficacy and side-effect profile of surgical treatment plus an oral antibiotic regiment for shoulder PJI with indolent organisms (C. acnes and CNS).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04636125
Study type Interventional
Source Rothman Institute Orthopaedics
Contact
Status Enrolling by invitation
Phase Phase 3
Start date September 24, 2019
Completion date September 24, 2021

See also
  Status Clinical Trial Phase
Completed NCT03856671 - Prophylatic Effect Preoperative Antibiotics With Mechanical Bowel Preparation in SSIs N/A